↓ Skip to main content

Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study

Overview of attention for article published in The Journal of Headache and Pain, November 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

news
1 news outlet
twitter
7 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
19 Mendeley